In the study presented here, we reveal a constitutive RelB DNA-binding activity in 21 out of 52 (approximately 40%) newly diagnosed MM patients, which is associated with high expression of a subset of anti-apoptotic NF-κB target genes, such as cIAP2. The gene discussed is NFKB1; the disease is Miyoshi myopathy.